Cellectis BioResearch and Stemgent Partner to Provide Custom Genome-Engineered iPS Cells
3/7/2013 10:06:25 AM
More...
|
Stemgent Completes Acquisition of Asterand plc (ATD.L)'s Human Tissue Business
8/1/2012 9:51:48 AM
More...
|
American Type Culture Collection and Stemgent Announce Collaborative Research Agreement to Advance Development of Novel Stem Cell Reagents and Pluripotent Cells
6/15/2011 7:06:49 AM
More...
|
Stemgent Finds $5.6 Million More
5/17/2010 7:21:23 AM
More...
|
Stemgent and Pfizer Inc. (PFE) Announce Collaboration
4/16/2010 11:10:07 AM
More...
|
Stemgent Betting $4.5 Million on Scottish Biotech
3/3/2010 7:47:23 AM
More...
|
Stemgent and Fate Therapeutics Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
4/24/2009 11:00:42 AM
More...
|
Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
4/23/2009 11:04:22 AM
More...
|
Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products
3/25/2009 9:24:30 AM
More...
|
Stemgent Raises $14 Million
3/10/2009 9:22:22 AM
More...
|